Given the evidence that IDO1 promotes T-cell anergy and suppresses tumour control [123], studies were carried out to examine the potential of inhibiting IDO1 to reduce tumour growth to unravel its role in BrCa progression. The gene discussed is IDO1; the disease is neoplasm.